ICD-10 Code D59.0 | Drug-induced autoimmune hemolytic anemia Symptoms, Diagnosis, Billing

Drug-induced autoimmune hemolytic anemia is a condition characterized by the destruction of red blood cells due to an autoimmune response triggered by certain medications. This condition is clinically significant as it can lead to severe anemia and requires prompt diagnosis and management. The ICD-10 Code D59.0 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.

What is ICD-10 Code D59.0 for Drug-induced autoimmune hemolytic anemia?

ICD-10 Code D59.0 represents Drug-induced autoimmune hemolytic anemia, a condition where the immune system mistakenly attacks and destroys red blood cells due to exposure to specific drugs. This code should be used in clinical documentation and billing when a patient presents with symptoms of hemolytic anemia following drug exposure, ensuring appropriate treatment and reimbursement.

ICD-10 Code D59.0 – Clinical Definition and Explanation of Drug-induced autoimmune hemolytic anemia

Drug-induced autoimmune hemolytic anemia occurs when certain medications provoke an immune response that leads to the destruction of red blood cells. This condition can progress rapidly and may require immediate medical intervention to prevent serious complications such as severe anemia or organ dysfunction.

Key Clinical Features:

• Recent history of medication use associated with hemolytic anemia.
• Symptoms such as fatigue, pallor, jaundice, and dark urine.
• Laboratory findings indicating decreased hemoglobin and elevated reticulocyte count.
• Positive direct Coombs test confirming autoimmune hemolysis.

ICD-10 Code D59.0 for Drug-induced autoimmune hemolytic anemia – SOAP Notes & Clinical Use

ICD-10 Code D59.0 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plan for Drug-induced autoimmune hemolytic anemia. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.

What Does ICD-10 Code D59.0 for Drug-induced autoimmune hemolytic anemia Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D59.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Drug-induced autoimmune hemolytic anemia. This code supports continuity of care, facilitates appropriate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code D59.0 – Drug-induced autoimmune hemolytic anemia

Drug-induced autoimmune hemolytic anemia often requires urgent medical attention and may necessitate hospitalization for management. Treatment focuses on discontinuing the offending drug and providing supportive care.

Antibiotic Therapy:

• Not applicable as this condition is not infectious.

Supportive Care:

• Transfusion of red blood cells if severe anemia is present.
• Intravenous immunoglobulin (IVIG) in severe cases.
• Monitoring of hemoglobin levels and reticulocyte counts.

Infection Control:

• Standard precautions to prevent secondary infections.

How to Document Symptoms of Drug-induced autoimmune hemolytic anemia (ICD-10 D59.0) in SOAP Notes

Subjective:

• Patient reports fatigue and weakness over the past week.
• History of recent medication use, including penicillin.
• Complaints of jaundice and dark urine.
• No prior history of hemolytic anemia.

Objective:

• Vital signs: BP 110/70 mmHg, HR 88 bpm, Temp 98.6°F.
• Physical exam reveals pallor and mild jaundice.
• Laboratory results: Hemoglobin 8.5 g/dL, reticulocyte count elevated.
• Direct Coombs test positive.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Drug-induced autoimmune hemolytic anemia (ICD-10 Code D59.0)

Assessment:

• Diagnosis: Drug-induced autoimmune hemolytic anemia, moderate severity.
• ICD-10 Code: D59.0.
• Recent penicillin use identified as a potential trigger.
• Patient requires monitoring and possible transfusion.

Plan:

• Discontinue penicillin and any other suspected medications.
• Administer blood transfusion if hemoglobin drops below 7 g/dL.
• Monitor hemoglobin and reticulocyte counts daily.
• Educate patient on signs of worsening anemia and follow-up care.

Treatment & Plan Section for ICD-10 Code D59.0 – Drug-induced autoimmune hemolytic anemia

• First-line treatment includes discontinuation of the offending drug.
• Transfusion of red blood cells may be necessary for severe anemia.
• Patient education on recognizing symptoms of anemia.
• Regular follow-up appointments to monitor hemoglobin levels.

Using ICD-10 Code D59.0 for Drug-induced autoimmune hemolytic anemia in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and medication history.
• Use D59.0 in conjunction with relevant lab findings in SOAP notes.
• Align treatment plans with clinical guidelines to support billing.
• Include detailed notes on patient education and follow-up care.

Related ICD-10 Codes Often Used with Drug-induced autoimmune hemolytic anemia

• D59.1 – Other autoimmune hemolytic anemias
• D50.9 – Iron deficiency anemia, unspecified

ICD-10 Code D59.0 in Medical Billing and Insurance for Drug-induced autoimmune hemolytic anemia

ICD-10 Code D59.0 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring proper reimbursement for services rendered.

Billing Notes:

• Document all relevant patient history and medication use.
• Use D59.0 in acute care settings for immediate treatment documentation.
• Ensure all clinical findings are clearly noted to support claims.
• Include follow-up care plans in documentation for continuity.

Common CPT Pairings: